| Nancy L Hagloch, MD | |
|
940 Royal Ave, Suite 350, Medford, OR 97504-6193 | |
| (541) 732-7460 | |
| (541) 732-7461 |
| Full Name | Nancy L Hagloch |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 940 Royal Ave, Medford, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184711749 | NPI | - | NPPES |
| 150483 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD20506 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Medford Medical Center | Medford, OR | Hospital |
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 5294623245 | 159 |
News Archive
An experimental "golden" potato could hold the power to prevent disease and death in developing countries where residents rely heavily upon the starchy food for sustenance, new research suggests.
Recent strides have been made to increase health care coverage for low income children in California, but a significant number of children in working poor families remain uninsured, according to a new study by researchers at the University of California, Berkeley.
A new study from the Howard Florey Institute in Melbourne may help explain why people who experimented with amphetamines, such as 'speed', as teenagers are more likely to become addicted and more susceptible to heart attack following re-use of the drug as adults.
Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
› Verified 3 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
An experimental "golden" potato could hold the power to prevent disease and death in developing countries where residents rely heavily upon the starchy food for sustenance, new research suggests.
Recent strides have been made to increase health care coverage for low income children in California, but a significant number of children in working poor families remain uninsured, according to a new study by researchers at the University of California, Berkeley.
A new study from the Howard Florey Institute in Melbourne may help explain why people who experimented with amphetamines, such as 'speed', as teenagers are more likely to become addicted and more susceptible to heart attack following re-use of the drug as adults.
Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
› Verified 3 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568547503 PECOS PAC ID: 5294623245 Enrollment ID: O20040310000315 |
News Archive
An experimental "golden" potato could hold the power to prevent disease and death in developing countries where residents rely heavily upon the starchy food for sustenance, new research suggests.
Recent strides have been made to increase health care coverage for low income children in California, but a significant number of children in working poor families remain uninsured, according to a new study by researchers at the University of California, Berkeley.
A new study from the Howard Florey Institute in Melbourne may help explain why people who experimented with amphetamines, such as 'speed', as teenagers are more likely to become addicted and more susceptible to heart attack following re-use of the drug as adults.
Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy L Hagloch, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Nancy L Hagloch, MD 940 Royal Ave, Suite 350, Medford, OR 97504-6193 Ph: (541) 732-7460 |
News Archive
An experimental "golden" potato could hold the power to prevent disease and death in developing countries where residents rely heavily upon the starchy food for sustenance, new research suggests.
Recent strides have been made to increase health care coverage for low income children in California, but a significant number of children in working poor families remain uninsured, according to a new study by researchers at the University of California, Berkeley.
A new study from the Howard Florey Institute in Melbourne may help explain why people who experimented with amphetamines, such as 'speed', as teenagers are more likely to become addicted and more susceptible to heart attack following re-use of the drug as adults.
Colorectal cancer is a leading cause of death in North America, but it is preventable if found at the colonic polyp stage. Currently, only 39% of colorectal cancer cases in the US are diagnosed at an early and treatable stage.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
› Verified 3 days ago
Anthony Eugene Ramsey, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 691 Murphy Road, Suite #202, Medford, OR 97504 Phone: 541-734-7733 Fax: 541-734-7744 | |
Dr. Daniel Alan Tomlinson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Ms. Carissa Marie Ross, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Daniel Albert Kahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2911 Siskiyou Blvd, Medford, OR 97504 Phone: 541-789-5982 Fax: 541-789-5983 | |
Timothy B Hutchings, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave, Ste 350, Medford, OR 97504 Phone: 541-732-7460 Fax: 541-732-7461 | |
Lorie Jane Morgan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2859 State St, Suite 102, Medford, OR 97504 Phone: 541-282-6518 Fax: 541-282-6510 | |
Jennifer Veit Hall Jackson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave Unit 350, Medford, OR 97504 Phone: 541-732-7460 |